From receiving a diagnosis of stage IV colon cancer to successfully completing his treatment and returning to his work, read the story of a cancer warrior
-
-
Venetoclax is a targeted therapy drug used to treat chronic lymphocytic leukemia, small lymphocytic lymphoma, and acute myeloid leukemia.
-
Trastuzumab is a targeted therapy drug used to treat Her-2 positive breast cancer, and Her-2 positive metastatic stomach cancer.
-
“Sunitinib is an oral targeted therapy drug used to treat advanced kidney cancer, advanced pancreatic neuroendocrine tumours (PNET), gastrointestinal stromal tumours (GIST), and thyroid cancer.”
-
Sorafenib is an oral targeted therapy drug used to treat advanced kidney cancer, liver cancer, thyroid cancer, gastrointestinal stromal tumors (GIST), and Angiosarcoma.
-
Rituximab is a targeted therapy drug used to treat various types of Non- Hodgkin’s lymphoma, Chronic lymphocytic leukemia, Rheumatoid arthritis, Granulomatosis with polyangiitis, and microscopic polyangiitis.
-
Pertuzumab is a targeted therapy drug used to treat HER2-positive breast cancer in combination with trastuzumab (another Her-2 targeted therapy drug) and chemotherapy.
-
“Panitumumab is a targeted therapy drug used to treat metastatic colorectal cancer that shows EGFR mutations.”
-
Paclitaxel is a chemotherapy drug used to treat Breast cancer, Ovarian cancer, Cervical Cancer, Head and neck cancers, Upper GI cancers like esophagus and gastric cancers, Pancreatic cancer, Non-small cell lung cancer, and Kaposi’s sarcoma.
-
Ofatumumab is chemotherapy and targeted therapy drug which is available in two brand names Arzerra and Kesimpta. Arzerra is approved for Chronic lymphocytic leukemia whereas Kesimpta is approved for Relapsing multiple sclerosis.
